Financial costs of assisted reproductive technology for patients in low- and middle-income countries: a systematic review
Open accessThe DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: What are the direct costs of assisted reproductive technology (ART), and how affordable is it for patients in low- and middle-income countries (LMICS)? SUMMARY ANSWER: Direct medical costs paid by patients for infertility treatment are significantly higher than annual average income and GDP per capita, pointing to unaffordability and the risk of catastrophic expenditure for those in need. WHAT IS KNOWN ALREADY: Infertility treatment is largely inaccessible to many people in LMICs. Our analysis shows that no study in LMICs has previously compared ART medical costs across countries in international dollar terms (US$PPP) or correlated the medical costs with economic indicators, financing mechanisms, and policy regulations. Previous systematic reviews on costs have been limited to high-income countries while those in LMICs have only focussed on descriptive analyses of these costs. STUDY DESIGN, SIZE, DURATION: Guided by the preferred reporting items for systematic reviews and meta-analyses (PRISMA), we searched PubMed, Web of Science, Cumulative Index of Nursing and Allied Health Literature, EconLit, PsycINFO, Latin American & Caribbean Health Sciences Literature, and grey literature for studies published in all languages from LMICs between 2001 and 2020. PARTICIPANTS/MATERIALS, SETTING, METHODS: The primary outcome of interest was direct medical costs paid by patients for one ART cycle. To gauge ART affordability, direct medical costs were correlated with the GDP per capita or average income of respective countries. ART regulations and public financing mechanisms were analyzed to provide information on the healthcare contexts in the countries. The quality of included studies was assessed using the Integrated Quality Criteria for Review of Multiple Study designs. MAIN RESULTS AND THE ROLE OF CHANCE: Of the 4062 studies identified, 26 studies from 17 countries met the inclusion criteria. There were wide disparities across countries in the direct medical costs paid by patients for ART ranging from USD2109 to USD18 592. Relative ART costs and GDP per capita showed a negative correlation, with the costs in Africa and South-East Asia being on average up to 200% of the GDP per capita. Lower relative costs in the Americas and the Eastern Mediterranean regions were associated with the presence of ART regulations and government financing mechanisms. LIMITATIONS, REASONS FOR CAUTION: Several included studies were not primarily designed to examine the cost of ART and thus lacked comprehensive details of the costs. However, a sensitivity analysis showed that exclusion of studies with below the minimum quality score did not change the conclusions on the outcome of interest. WIDER IMPLICATIONS OF THE FINDINGS: Governments in LMICs should devise appropriate ART regulatory policies and implement effective mechanisms for public financing of fertility care to improve equity in access. The findings of this review should inform advocacy for ART regulatory frameworks in LMICs and the integration of infertility treatment as an essential service under universal health coverage. STUDY FUNDING/COMPETING INTEREST(S): This work received funding from the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a cosponsored programme executed by the World Health Organization (WHO). The authors declare no competing interests. TRIAL REGISTRATION NUMBER: This review is registered with PROSPERO, CRD42020199312.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due to high cost and/or unaffordability, ART remains out of reach for many, even in resource-rich countries (Dyer et al., 2020; ASRM The Ethics Committee, 2021; Njagi et al., 2023).”
From Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature (2024) · cites this paper as Njagi et al., 2023
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Systematic reviews have shown that individuals with infertility problems in LMICs are less likely to have access to any form of ART [31,34], even routine medical care, including psychosocial interventions [35].”
The cited source says what the claim attributes to it.
In the citing paper
“Infertility treatment is disproportionately underutilized in LMICs [30,31] due to the high cost of treatment and the limited financial resources of those affected.”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“While psychosocial interventions are conceptualized in high-income countries and incorporated in the health systems, LMICs are yet to incorporate them in the management of infertility [31].”
From Psychosocial interventions for improving marital intimacy, sexual satisfaction, and quality of life of women and couples with infertility problems in low and middle-income countries: Systematic review protocol (2025) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1×
“In keeping with the study protocol published in the PROSPERO database (CRD42020199312) and elsewhere (Njagi et al., 2020), this study was conducted according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement (Moher et al., 2009).”
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Boivin, J., Bunting, L., Collins, J. A., & Nygren, K. G. (2007) · Human Reproduction · doi:10.1093/humrep/dem046 · Cited by 2,437 · cited 2×
“While reported prevalence estimates vary widely due to different methodologies, global estimates show that between 48.5 and 72.4 million couples have infertility (Boivin et al., 2007; Mascarenhas et al., 2012).”
InfluentialDevelopment of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)
Downes, M. J., Brennan, M. L., Williams, H. C., & Dean, R. S. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011458 · Cited by 2,376 · cited 1×
“For cross-sectional studies, we applied the criteria for non-controlled studies complemented by the quality assessment tool for observational and cross-sectional studies provided by the National Institutes of Health (Downes et al., 2016; Ma et al., 2020).”
MethodMascarenhas, M. N., Flaxman, S. R., Boerma, T., Vanderpoel, S., & Stevens, G. A. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001356 · Cited by 2,312 · cited 4×
“However, infertility is itself a widely prevalent cause of significant health burden for millions of people (Makuch et al., 2010; Mascarenhas et al., 2012; Cox et al., 2022) that should be the addressed alongside other health needs to achieve universal health coverage (Starrs et al.”
BackgroundInfluentialInternational Statistical Classification of Diseases and Related Health Problems 10th Revision
(2013) · A Companion to the Classification of Mental Disorders · doi:10.1093/med/9780199669493.005.0005 · Cited by 2,059
Inhorn, M. C., & Patrizio, P. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv016 · Cited by 1,926 · cited 2×
“intervention throughout the world (Bitler and Schmidt, 2012; Inhorn and Patrizio, 2015; Sharma et al., 2018).”
BackgroundMa, L.-L., Wang, Y.-Y., Yang, Z.-H., Huang, D., Weng, H., & Zeng, X.-T. (2020) · Military Medical Research · doi:10.1186/s40779-020-00238-8 · Cited by 1,648
Starrs, A. M., Ezeh, A. C., Barker, G., Basu, A., Bertrand, J. T., Blum, R., Coll-Seck, A. M., Grover, A., Laski, L., Roa, M., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30293-9 · Cited by 1,598 · cited 2×
“, 2022) that should be the addressed alongside other health needs to achieve universal health coverage (Starrs et al., 2018).”
BackgroundThe International Glossary on Infertility and Fertility Care, 2017
Zegers-Hochschild, F., Adamson, G. D., Dyer, S., Racowsky, C., de Mouzon, J., Sokol, R., Rienzi, L., Sunde, A., Schmidt, L., Cooke, I. D., et al. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.06.005 · Cited by 1,505
Self-citationCox, C. M., Thoma, M. E., Tchangalova, N., Mburu, G., Bornstein, M. J., Johnson, C. L., & Kiarie, J. (2022) · Human Reproduction Open · doi:10.1093/hropen/hoac051 · Cited by 506 · cited 4×
“However, infertility is itself a widely prevalent cause of significant health burden for millions of people (Makuch et al., 2010; Mascarenhas et al., 2012; Cox et al., 2022) that should be the addressed alongside other health needs to achieve universal health coverage (Starrs et al.”
BackgroundInfluentialSelf-citationThe economic impact of assisted reproductive technology: a review of selected developed countries
Chambers, G. M., Sullivan, E. A., Ishihara, O., Chapman, M. G., & Adamson, G. D. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.04.029 · Cited by 438 · cited 1×
“Furthermore, while other studies (Chambers et al., 2009) have assessed ART cost and its variations in HICs, this review focuses on LMICs.”
BackgroundInternational disparities in access to infertility services
Nachtigall, R. D. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.08.066 · Cited by 347 · cited 1×
“However, there are marked disparities in the availability, quality, and delivery of infertility care services between high-income countries (HICs) and low- and middle-income countries (LMICs) (Nachtigall, 2006).”
BackgroundCurrent Practices and Controversies in Assisted Reproduction
Vayena, E., Rowe, P. J., & Griffin, P. (2002) · Cited by 347
The costs and consequences of assisted reproductive technology: an economic perspective
Connolly, M. P., Hoorens, S., Chambers, G. M., & on behalf of the ESHRE Reproduction and Society Task Force (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq013 · Cited by 197 · cited 1×
“Given the documented importance of costs and levels of reimbursement by governments as well as disposable income in determining the affordability of ART (Connolly et al., 2010; Inhorn and Gürtin, 2012; Abedini et al., 2016), more research is needed on financing of infertility treatment in LMICs.”
BackgroundChambers, G. M., Hoang, V. P., Sullivan, E. A., Chapman, M. G., Ishihara, O., Zegers-Hochschild, F., Nygren, K. G., & Adamson, G. D. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.09.005 · Cited by 168 · cited 2×
“Furthermore, even in HICs, the level of access to ART treatments is reported to be sensitive to the costs paid by patients (Chambers et al., 2014).”
BackgroundThe economic impact of infertility on women in developing countries ‑ a systematic review.
Dyer, S., & Patel, M. (2012) · PubMed Central · Cited by 167
Self-citationIVF and other ART in low- and middle-income countries: a systematic landscape analysis
Chiware, T. M., Vermeulen, N., Blondeel, K., Farquharson, R., Kiarie, J., Lundin, K., Matsaseng, T. C., Ombelet, W., & Toskin, I. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmaa047 · Cited by 157 · cited 2×
“Further opportunities to mitigate costs of treatment in low resource settings could include the implementation of low-cost options for ART (Chiware et al., 2021); however, low cost should not lead to a compromise on quality (Aleyamma et al., 2011; Arakkal et al., 2020).”
BackgroundSelf-citationConsequences of infertility in developing countries
Rouchou, B. (2013) · Perspectives in Public Health · doi:10.1177/1757913912472415 · Cited by 154 · cited 1×
“Apart from being costly, ART is also often timeconsuming, physically and emotionally strenuous, and without certainty about its outcome (Domar et al., 2012; Rouchou, 2013).”
BackgroundUtilization of Infertility Treatments: The Effects of Insurance Mandates
Bitler, M. P., & Schmidt, L. (2012) · Demography · doi:10.1007/s13524-011-0078-4 · Cited by 154 · cited 2×
“intervention throughout the world (Bitler and Schmidt, 2012; Inhorn and Patrizio, 2015; Sharma et al., 2018).”
BackgroundInfertility & assisted reproduction
Sharma, R. S., Saxena, R., & Singh, R. K. (2018) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_636_18 · Cited by 145 · cited 2×
“intervention throughout the world (Bitler and Schmidt, 2012; Inhorn and Patrizio, 2015; Sharma et al., 2018).”
BackgroundZingg, W., Castro-Sanchez, E., Secci, F. V., Edwards, R., Drumright, L. N., Sevdalis, N., & Holmes, A. H. (2016) · Public Health · doi:10.1016/j.puhe.2015.10.012 · Cited by 143 · cited 3×
“The ‘decision matrix’ establishes the robustness of the study based on two factors: a mandatory criterion that considers some of the quality elements as mandatory to be met and a minimum score requirement for each study type that equates to 60% of the maximum total points attributable to a specific study design to gua…”
BackgroundMethodInfluentialWiersema, N. J., Drukker, A. J., Dung, M. B. T., Nhu, G. H., Nhu, N. T., & Lambalk, C. B. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-54 · Cited by 111 · cited 2×
“11 (Wiersema et al., 2006) Consequences of infertility in developing countries: results of a questionnaire and interview survey in the South of Vietnam.”
BackgroundWhyle, E. B., & Olivier, J. (2016) · Health Policy and Planning · doi:10.1093/heapol/czw075 · Cited by 109 · cited 1×
“By harnessing the resources of the private sector, states can use public–private engagement as a tool to close funding gaps in healthcare delivery and advance public health goals (Whyle and Olivier, 2016; Babacan, 2021).”
BackgroundCasebolt, T. (2020) · Sexual & Reproductive Healthcare · doi:10.1016/j.srhc.2020.100485 · Cited by 109 · cited 1×
“Governments’ insufficient capacity or commitment to respond to infertility means that many couples pay for their treatment out of pocket (OOP), making cost an important barrier to access (Roa-Meggo, 2012; Casebolt, 2020), likely resulting in treatment inequalities (Dyer et al., 2013).”
Background(2011) · Europe PMC (PubMed Central) · Cited by 107
Domar, A., Gordon, K., Garcia-Velasco, J., La Marca, A., Barriere, P., & Beligotti, F. (2012) · Human Reproduction · doi:10.1093/humrep/des016 · Cited by 100
IVF in Africa: what is it all about?
Ombelet, W., & Onofre, J. (2019) · PubMed Central · Cited by 90
Dyer, S. J., Sherwood, K., McIntyre, D., & Ataguba, J. E. (2013) · Human Reproduction · doi:10.1093/humrep/det290 · Cited by 82 · cited 6×
“At the same time, patients are at a high risk of incurring catastrophic expenditure because not all those unable to afford it are willing to forgo the treatment due to cost, given the strong desire and social expectations to have a child (Dyer et al., 2013), rendering infertility a ‘medical and social poverty trap’ fo…”
BackgroundInfluentialSelf-citationManagement of infertility in low resource countries
Sharma, S., Mittal, S., & Aggarwal, P. (2009) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02311.x · Cited by 81 · cited 1×
“Even though ART has existed for over four decades, it remains either unavailable or inaccessible to most people in resource-poor settings (Sharma et al., 2009; Allahbadia, 2013; Botha et al., 2018; Ombelet and Onofre, 2019).”
BackgroundSeeking conception: Experiences of urban Indian women with in vitro fertilisation
Widge, A. (2005) · Patient Education and Counseling · doi:10.1016/j.pec.2005.07.014 · Cited by 80 · cited 2×
“…Region (EMR) Facility-based review of infertility care in Sudan Qualitative ART centers Interviews of lead physicians Private 7 ART centers 24 (Widge, 2005) Seeking conception: Experiences of urban Indian women with in vitro fertilization 2005 1997 and 2000 India South-East Asian Region…”
BackgroundMethodNahar, P., & Richters, A. (2011) · Anthropology & Medicine · doi:10.1080/13648470.2011.615911 · Cited by 69 · cited 2×
“25 (Nahar and Richters, 2011) Suffering of childless women in Bangladesh: the intersection of social identities of gender and class 2010 2003–2004 Bangladesh South-East Asian Region (SEAR) Addresses the impact of class differences on the gender-related suffering of childless women in the socially very hierarchically s…”
BackgroundAccess to Infertility Care in the Developing World: The Family Promotion Gap
Asemota, O., & Klatsky, P. (2015) · Seminars in Reproductive Medicine · doi:10.1055/s-0034-1395274 · Cited by 68 · cited 2×
“…is often neglected due to many competing health needs, as well as the relatively high fertility rates and large family sizes, which may not only mask infertility in populations (Asemota and Klatsky, 2015), but may even have created disincentives to public funding of infertility treatment.”
BackgroundA cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women
Khoa, L. D., Vuong, L. N., Ho, T. M., Dang, V. Q., Pham, T. D., Pham, C. T., Norman, R. J., & Mol, B. W. (2018) · Human Reproduction · doi:10.1093/humrep/dey253 · Cited by 62 · cited 1×
“…region (continent) Main objective/aim of the study Research design Study target population Data source Type of health provider Sample size 1 (Le et al., 2018) A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women 2018 June 2015 and April 2016 Vietnam…”
BackgroundInfertility, Inequality, and How Lack of Insurance Coverage Compromises Reproductive Autonomy
Insogna, I. G., & Ginsburg, E. S. (2018) · The AMA Journal of Ethic · doi:10.1001/amajethics.2018.1152 · Cited by 51 · cited 1×
“As a result, in many LMICs, government-funded infertility treatments are either limited or nonexistent and are excluded from health insurance packages (Adewumi, 2017), despite the associated high costs to patients (Ombelet, 2011; Insogna and Ginsburg, 2018).”
BackgroundGerrits, T. (2016) · Reproductive Biomedicine & Society Online · doi:10.1016/j.rbms.2016.05.002 · Cited by 49 · cited 2×
“…costs incurred by ART centers are partly due to the complexity of the procedure, they are also strongly influenced by the need for highly skilled staff and sophisticated equipment as well as drugs and consumables, all of which are largely imported into LMICs (Huyser and Boyd, 2013; Gerrits, 2016).”
BackgroundAffordable ART: a different perspective
Aleyamma, T. K., Kamath, M. S., Muthukumar, K., Mangalaraj, A. M., & George, K. (2011) · Human Reproduction · doi:10.1093/humrep/der323 · Cited by 44 · cited 4×
“, 2021); however, low cost should not lead to a compromise on quality (Aleyamma et al., 2011; Arakkal et al., 2020).”
BackgroundInfluentialKlitzman, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171939 · Cited by 42 · cited 1×
“It is possible that costs may vary across countries based on economic parameters, laws, regulations, and insurance coverage for assisted reproduction (Klitzman, 2017).”
BackgroundNjagi, P., Groot, W. N. J., Arsenijevic, J., Dyer, S., Mburu, G., & Kiarie, J. N. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-042951 · Cited by 42 · cited 2×
“In keeping with the study protocol published in the PROSPERO database (CRD42020199312) and elsewhere (Njagi et al., 2020), this study was conducted according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement (Moher et al.”
MethodSelf-citationLow priority level for infertility services within the public health sector: a Brazilian case study
Makuch, M. Y., Petta, C. A., Osis, M. J. D., & Bahamondes, L. G. (2009) · Human Reproduction · doi:10.1093/humrep/dep405 · Cited by 41 · cited 5×
“21 (Makuch et al., 2010) Low priority level for infertility services within the public health sector: A Brazilian case study 2010 June 2008 to June 2009 Brazil Region of the Americas (AMR) Assessed the availability of public sector infertility services, including assisted reproduction technology (ART), in Brazil.”
BackgroundInfluentialAvailability, effectiveness and safety of ART in sub-Saharan Africa: a systematic review
Botha, B., Shamley, D., & Dyer, S. (2018) · Human Reproduction Open · doi:10.1093/hropen/hoy003 · Cited by 41 · cited 1×
“Even though ART has existed for over four decades, it remains either unavailable or inaccessible to most people in resource-poor settings (Sharma et al., 2009; Allahbadia, 2013; Botha et al., 2018; Ombelet and Onofre, 2019).”
BackgroundSelf-citationMakuch, M. Y., de Pádua, K. S., Petta, C. A., Osis, M. J. D., & Bahamondes, L. G. (2011) · Human Reproduction · doi:10.1093/humrep/der158 · Cited by 40 · cited 2×
“…..care where ART costs were restricted to payments for medications (Brazil; Makuch et al., 2010, 2011) or subsidized by the institution (South Africa; Dyer and Kruger, 2012).”
BackgroundDyer, S., & Kruger, T. F. (2012) · South African Medical Journal · doi:10.7196/samj.5311 · Cited by 33 · cited 3×
“…procedure, cost, and some challenges of IVF in Iran Quantitative (cross-sectional) ART sites Health personnel Public and private 52 ART units 9 (Dyer and Kruger, 2012) Assisted reproductive technology in South Africa: First results generated from the South African Register of Assisted…”
BackgroundInfluentialSelf-citationAssisted Reproductive Technology in Iran: The First National Report on Centers, 2011.
Abedini, M., Ghaheri, A., & Samani, R. O. (2016) · PubMed Central · doi:10.22074/ijfs.2016.5044 · Cited by 32 · cited 2×
“Qualitative review Health professionals and infertile patients Tariff lists Private 2 private ART clinics 8 (Abedini et al., 2016) Assisted Reproductive Technology in Iran: The First National Report on Centers, 2011 2016 2011 Iran Eastern Mediterranean Region (EMR) First national report on Iranian…”
BackgroundCost-benefit Analysis of IUI and IVF based on willingness to pay approach; case study: Iran
Darvishi, A., Goudarzi, R., Zadeh, V. H., & Barouni, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231584 · Cited by 30 · cited 3×
“ART financing by the governments in LMICs depends mainly on the cost–benefit value perceived by the state, given the relatively high ART costs (Darvishi et al., 2020).”
BackgroundMethodInfluentialART in South Africa: The price to pay.
Huyser, C., & Boyd, L. S. (2013) · PubMed Central · Cited by 23
Infertility in developing countries: funding the project
Sallam, H. N. (2008) · ESHRE Monographs · doi:10.1093/humrep/den144 · Cited by 17 · cited 1×
“This is particularly relevant given that a sustainable establishment of infertility services in developing countries depends on models that involve treatment financing by governments (Sallam, 2008).”
BackgroundPublic–Private Partnerships for Global Health
Babacan, H. (2021) · Springer eBooks · doi:10.1007/978-3-030-45009-0_117 · Cited by 17
IVF in Developing Economies and Low Resource Countries: An Overview
Allahbadia, G. N. (2013) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-013-0477-0 · Cited by 15 · cited 1×
“Even though ART has existed for over four decades, it remains either unavailable or inaccessible to most people in resource-poor settings (Sharma et al., 2009; Allahbadia, 2013; Botha et al., 2018; Ombelet and Onofre, 2019).”
BackgroundConnolly, M. P., Panda, S., Mburu, G., Matsaseng, T., & Kiarie, J. (2021) · Reproductive Biomedicine & Society Online · doi:10.1016/j.rbms.2020.08.001 · Cited by 14 · cited 3×
“In this regard, financing ART may represent a good governmental investment by enhancing immediate reproductive health while also generating positive financial returns in future tax contributions, including in LMICs (Connolly et al., 2021).”
BackgroundInfluentialSelf-citationHammarberg, K., Trounson, A. O., McBain, J., Matthews, P. A., Robertson, T., Robertson, F., Magli, M. C., Mhlanga, T., Makurumure, T., & Marechera, F. (2018) · Human Reproduction Open · doi:10.1093/hropen/hoy017 · Cited by 12 · cited 2×
“16 (Hammarberg et al., 2018) Improving access to ART in lowincome settings through knowledge transfer: a case study from Zimbabwe 2018 Not reported Zimbabwe African Region (AFR) Describes a model for improving access to ART in low-resource settings.”
BackgroundAssisted reproduction and justice: Threats to a new model in a low‐ and middle‐income country
Hall, D. R., & Hanekom, G. (2019) · Developing World Bioethics · doi:10.1111/dewb.12252 · Cited by 10 · cited 1×
“This means that in LMICs, ART can generally only be accessed by the well-off, paying OOP via predominantly private health facilities (Hall and Hanekom, 2020).”
BackgroundWu, B. (2019) · Health Economics · doi:10.1002/hec.3900 · Cited by 9 · cited 1×
“Moreover, the willingness and financial ability to undergo more than one ART cycle often depend on the OOP payments incurred (Wu, 2019).”
BackgroundLass, A., Chaudary, W., & Lass, G. (2019) · Journal of Medical Economics · doi:10.1080/13696998.2019.1609484 · Cited by 9 · cited 1×
“It is possible that costs may vary across countries based on economic parameters, laws, regulations, and insurance coverage for assisted reproduction (Klitzman, 2017).”
BackgroundThe 5 main challenges faced in infertility care in Cameroon
Bell, E. G., Gwet, B. B., Akoung, N., & Fiadjoe, M. (2018) · Global Reproductive Health · doi:10.1097/grh.0000000000000016 · Cited by 9 · cited 2×
“26 (Gwet-Bell et al., 2018) The 5 main challenges faced in infertility care in Cameroon 2018 Not reported Cameroon African Region (AFR) Summarises the 5 main challenges in infertility care that Cameroonians face Qualitative review Review (not reported) Review (not reported) Public and private Review (not reported)”
BackgroundInfertility treatment financing in Nigeria
Adewumi, E. (2017) · Nigerian Journal of Health Sciences · doi:10.4103/njhs.njhs_28_16 · Cited by 7 · cited 1×
“As a result, in many LMICs, government-funded infertility treatments are either limited or nonexistent and are excluded from health insurance packages (Adewumi, 2017), despite the associated high costs to patients (Ombelet, 2011; Insogna and Ginsburg, 2018).”
BackgroundLa infertilidad como problema de salud pública en el Perú
Roa-Meggo, Y. (2014) · Revista Peruana de Ginecología y Obstetricia · doi:10.31403/rpgo.v58i77 · Cited by 4
Four years of IVF/ICSI experience in Kampala (Uganda)
Platteau, P., Desmet, B., Odoma, G., Albano, C., Devroey, P., & Sali, E. T. (2008) · ESHRE Monographs · doi:10.1093/humrep/den161 · Cited by 4 · cited 2×
“…region (continent) Main objective/aim of the study Research design Study target population Data source Type of health provider Sample size 15 (Platteau et al., 2008) Four years of IVF/ICSI experience in Kampala (Uganda) 2008 Not reported Uganda African Region (AFR) Analysis of an ART clinic…”
BackgroundArakkal, D., Mascarenhas, M., Mangalaraj, A. M., Karthikeyan, M., Prasad, J., Kunjummen, A. T., & Kamath, M. S. (2020) · Fertility & Reproduction · doi:10.1142/s2661318220500164 · Cited by 3 · cited 1×
“Further opportunities to mitigate costs of treatment in low resource settings could include the implementation of low-cost options for ART (Chiware et al., 2021); however, low cost should not lead to a compromise on quality (Aleyamma et al., 2011; Arakkal et al., 2020).”
BackgroundInseminación intrauterina en mayores de 38 años, ¿vale la pena?
Manzur, A., Macaya, R., & Gajardo, G. (2014) · Revista Peruana de Ginecología y Obstetricia · doi:10.31403/rpgo.v58i91 · Cited by 2 · cited 1×
“Qualitative review Review (not reported) Review (not reported) Private and public Review (not reported) 19 (Manzur et al., 2012) Inseminación intrauterina en may- ores de 38 a~nos, >vale la pena?”
Determining infertility treatment costs and out of pocket payments imposed on couples
Ranjbar, M., Rafies, S., Abduli, A. M., Tafti, A. D., Abdarzadeh, N., Saghafi, F., & Bahrami, M. A. (2016) · East African Medical Journal · Cited by 2
Cost Incurred And Source Of Finance For The Treatment Of Infertility
Sangamithra, A. (2018) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.1283320 · Cited by 1
Cost Incurred and Source of Finance for the Treatment of Infertility
Sangamithra, A. (2018) · Shanlax International Journal of Economics · Cited by 1
Research works printed but not linked: 9
- International Federation of Fertility Societies’ Surveillance (IFFS), 2019, Global trends in reproductive policy and practice, Glob Reprod Health, 4, e29
- Inhorn, 2012, Infertility and assisted reproduction in the muslim middle east: social, religious, and resource considerations, Facts Views Vis ObGyn, 6, 24
- Khalifa, 2012, Reviewing infertility care in Sudan; socio-cultural, policy and ethical barriers, Facts Views Vis ObGyn, 53
- Sangamithra, 2015, An economic analysis of socio-economic variables and treatment cost of infertility, Shanlax Int J Econ, 3, 5
- Tangwa, 2002, ART and African sociocultural practices: worldview, belief and value systems with particular reference to francophone Africa, Vayena E Curr Pract Controv Assist Reprod, 5, 55
- WHO, 2020, Infertility Fact Sheet
- World Bank, 2021, Low and Middle Income Countries: World Bank Open Data
- World Bank, 2021, PovcalNet
- World Bank, 2021, GDP per capita, PPP (Current International $) International Comparison Program, World Development Indicators Database
Cited by
Fauser, B. C. J. M., Adamson, G. D., Boivin, J., Chambers, G. M., de Geyter, C., Dyer, S., Inhorn, M. C., Schmidt, L., Serour, G. I., Tarlatzis, B., et al. (2024) · Human Reproduction Update · doi:10.1093/humupd/dmad028 · Cited by 224
“Due to high cost and/or unaffordability, ART remains out of reach for many, even in resource-rich countries (Dyer et al. , 2020; ASRM The Ethics Committee, 2021; Njagi et al. , 2023).”
BackgroundSelf-citationEmbryo selection through artificial intelligence versus embryologists: a systematic review
Salih, M., Austin, C., Warty, R. R., Tiktin, C., Rolnik, D. L., Momeni, M., Rezatofighi, H., Reddy, S., Smith, V., Vollenhoven, B. J., et al. (2023) · Human Reproduction Open · doi:10.1093/hropen/hoad031 · Cited by 191
“Annually, the estimated number of couples experiencing infertility worldwide is around 17.5% of the adult population (one in six) (Njagi et al. , 2023).”
InfluentialGaillard, L., Barouki, R., Blanc, É., Coumoul, X., & Andréau, K. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.07.021 · Cited by 143
Feng, J., Wu, Q., Liang, Y., Liang, Y., & Bin, Q. (2025) · Reproductive Health · doi:10.1186/s12978-025-01966-7 · Cited by 115
“In low-and middle-income countries, the lack of gov-ernment-funded infertility treatments and insurance coverage further limits access, leaving many couples to pay out of pocket, which can lead to significant financial hardship [13].”
Wang, Y., Li, R., Yang, R. J., Zheng, D., Zeng, L., Lian, Y., Zhu, Y., Zhao, J., Liang, X., Li, W., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02416-9 · Cited by 86
Metadata
- Authors
- Njagi, P., Groot, W., Arsenijevic, J., Dyer, S., Mburu, G., & Kiarie, J.
- Affiliations
- United Nations University – Maastricht Economic and Social Research Institute on Innovation and Technology (NL)
- Utrecht University (NL)
- University of Cape Town (ZA)
- World Health Organization (CH)
- Corresponding author
- Njagi, Purity
- Venue
- Human Reproduction Open
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-01-01
- Volume
- 2023
- Issue
- 2
- Pages
- hoad007-hoad007
- ISSN
- 2399-3529 (ISSN-L)
- PMC
- PMC10029849
- OpenAlex
- W4322730891
- Cited by
- 277
- References
- 65
- Citations by year
- 2026: 86 · 2025: 106 · 2024: 71 · 2023: 14
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Human Reproduction Open (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, cc-by)
- Funders
- UNDP-UNFPA-UNICEF-WHO-World Bank
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Systems and Reforms
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- assisted reproduction, infertility treatment, direct medical costs, patient affordability, low- and middle-income countries, GDP per capita, ART regulation, access to fertility care, health policy implications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.